JP2003529592A - 結晶性医薬 - Google Patents
結晶性医薬Info
- Publication number
- JP2003529592A JP2003529592A JP2001572482A JP2001572482A JP2003529592A JP 2003529592 A JP2003529592 A JP 2003529592A JP 2001572482 A JP2001572482 A JP 2001572482A JP 2001572482 A JP2001572482 A JP 2001572482A JP 2003529592 A JP2003529592 A JP 2003529592A
- Authority
- JP
- Japan
- Prior art keywords
- lopinavir
- solid
- crystalline form
- infrared spectrum
- peak
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/10—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53825700A | 2000-03-30 | 2000-03-30 | |
US09/538,257 | 2000-03-30 | ||
US09/793,536 | 2001-02-27 | ||
US09/793,536 US6608198B2 (en) | 2000-03-30 | 2001-02-27 | Crystalline pharmaceutical |
PCT/US2001/009112 WO2001074787A2 (en) | 2000-03-30 | 2001-03-21 | Crystalline pharmaceutical |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003529592A true JP2003529592A (ja) | 2003-10-07 |
Family
ID=27065762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001572482A Pending JP2003529592A (ja) | 2000-03-30 | 2001-03-21 | 結晶性医薬 |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1268442A2 (ko) |
JP (1) | JP2003529592A (ko) |
KR (1) | KR100773258B1 (ko) |
CN (2) | CN101066952A (ko) |
AR (2) | AR033360A1 (ko) |
AU (3) | AU5092001A (ko) |
BG (1) | BG107165A (ko) |
BR (1) | BR0109433A (ko) |
CA (1) | CA2403635A1 (ko) |
CZ (1) | CZ20023529A3 (ko) |
HU (1) | HUP0302675A3 (ko) |
IL (1) | IL151551A0 (ko) |
MX (1) | MXPA02009559A (ko) |
MY (1) | MY128296A (ko) |
NO (1) | NO325005B1 (ko) |
NZ (1) | NZ521183A (ko) |
PE (1) | PE20011232A1 (ko) |
PL (1) | PL359727A1 (ko) |
SA (2) | SA01220270B1 (ko) |
SK (1) | SK14832002A3 (ko) |
TW (1) | TWI284640B (ko) |
WO (1) | WO2001074787A2 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013503176A (ja) * | 2009-08-27 | 2013-01-31 | メルク・シャープ・エンド・ドーム・コーポレイション | C型肝炎ウイルスのプロテアーゼ阻害薬の調製方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6608198B2 (en) | 2000-03-30 | 2003-08-19 | Abbott Laboratories | Crystalline pharmaceutical |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8445506B2 (en) | 2009-02-06 | 2013-05-21 | Hetero Research Foundation | Polymorphs of lopinavir |
CN112830899A (zh) * | 2021-01-18 | 2021-05-25 | 合肥华方医药科技有限公司 | 一种洛匹那韦新晶型及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5914332A (en) * | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
WO1998057648A1 (en) * | 1997-06-16 | 1998-12-23 | Vertex Pharmaceuticals Incorporated | Methods of increasing the bioavailability of stable crystal polymorphs of a compound |
-
2001
- 2001-03-07 MY MYPI20011034A patent/MY128296A/en unknown
- 2001-03-21 WO PCT/US2001/009112 patent/WO2001074787A2/en active IP Right Grant
- 2001-03-21 NZ NZ521183A patent/NZ521183A/en not_active IP Right Cessation
- 2001-03-21 AU AU5092001A patent/AU5092001A/xx active Pending
- 2001-03-21 CN CNA2007101123988A patent/CN101066952A/zh active Pending
- 2001-03-21 PL PL35972701A patent/PL359727A1/xx not_active Application Discontinuation
- 2001-03-21 JP JP2001572482A patent/JP2003529592A/ja active Pending
- 2001-03-21 KR KR1020027012849A patent/KR100773258B1/ko active IP Right Grant
- 2001-03-21 BR BR0109433-5A patent/BR0109433A/pt not_active Application Discontinuation
- 2001-03-21 HU HU0302675A patent/HUP0302675A3/hu unknown
- 2001-03-21 AU AU2001250920A patent/AU2001250920B2/en not_active Revoked
- 2001-03-21 SK SK1483-2002A patent/SK14832002A3/sk not_active Application Discontinuation
- 2001-03-21 CZ CZ20023529A patent/CZ20023529A3/cs unknown
- 2001-03-21 IL IL15155101A patent/IL151551A0/xx unknown
- 2001-03-21 CN CNB018076882A patent/CN1330639C/zh not_active Expired - Lifetime
- 2001-03-21 CA CA002403635A patent/CA2403635A1/en not_active Abandoned
- 2001-03-21 EP EP01924250A patent/EP1268442A2/en not_active Withdrawn
- 2001-03-21 MX MXPA02009559A patent/MXPA02009559A/es active IP Right Grant
- 2001-03-29 AR ARP010101522A patent/AR033360A1/es not_active Application Discontinuation
- 2001-03-30 PE PE2001000299A patent/PE20011232A1/es not_active Application Discontinuation
- 2001-05-02 TW TW090107717A patent/TWI284640B/zh active
- 2001-08-07 SA SA01220270A patent/SA01220270B1/ar unknown
- 2001-08-07 SA SA06270303A patent/SA06270303B1/ar unknown
-
2002
- 2002-09-30 NO NO20024679A patent/NO325005B1/no not_active Application Discontinuation
- 2002-10-03 BG BG107165A patent/BG107165A/bg unknown
-
2005
- 2005-06-29 AR ARP050102702A patent/AR049560A2/es unknown
-
2006
- 2006-09-27 AU AU2006222711A patent/AU2006222711A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013503176A (ja) * | 2009-08-27 | 2013-01-31 | メルク・シャープ・エンド・ドーム・コーポレイション | C型肝炎ウイルスのプロテアーゼ阻害薬の調製方法 |
Also Published As
Publication number | Publication date |
---|---|
BR0109433A (pt) | 2004-08-10 |
IL151551A0 (en) | 2003-04-10 |
NZ521183A (en) | 2004-03-26 |
TWI284640B (en) | 2007-08-01 |
AU2006222711A1 (en) | 2006-10-19 |
AU2001250920B2 (en) | 2006-06-29 |
CN1330639C (zh) | 2007-08-08 |
EP1268442A2 (en) | 2003-01-02 |
WO2001074787A2 (en) | 2001-10-11 |
PE20011232A1 (es) | 2001-12-08 |
CZ20023529A3 (cs) | 2003-02-12 |
CN1422259A (zh) | 2003-06-04 |
AR033360A1 (es) | 2003-12-17 |
NO20024679L (no) | 2002-09-30 |
AR049560A2 (es) | 2006-08-16 |
HUP0302675A3 (en) | 2004-03-29 |
CN101066952A (zh) | 2007-11-07 |
AU5092001A (en) | 2001-10-15 |
MXPA02009559A (es) | 2003-05-21 |
NO20024679D0 (no) | 2002-09-30 |
KR20030011807A (ko) | 2003-02-11 |
SA06270303B1 (ar) | 2009-08-02 |
BG107165A (bg) | 2003-07-31 |
CA2403635A1 (en) | 2001-10-11 |
WO2001074787A3 (en) | 2002-02-07 |
HUP0302675A2 (hu) | 2003-12-29 |
SK14832002A3 (sk) | 2003-02-04 |
NO325005B1 (no) | 2008-01-14 |
PL359727A1 (en) | 2004-09-06 |
MY128296A (en) | 2007-01-31 |
SA01220270B1 (ar) | 2006-11-14 |
KR100773258B1 (ko) | 2007-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8796451B2 (en) | Crystalline pharmaceutical | |
AU2011281381B2 (en) | Salt and solvates of a tetrahydroisoquinoline derivative | |
EA001180B1 (ru) | Тригидрат мезилата 5-(2-(4-(1,2-бензизотиазол-3-ил)пиперазин-1-ил)этил)-6-хлор-1,3-дигидро-2н-индол-2-она, фармацевтическая композиция и способ лечения психического расстройства | |
WO2022258060A1 (zh) | 一种lanifibranor的晶型及其制备方法 | |
AU2006222711A1 (en) | Crystalline pharmaceutical | |
US8207217B2 (en) | Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan | |
KR101596554B1 (ko) | 펩타이드계 물질의 결정체 및 그의 제조방법과 용도 | |
AU2001250920A1 (en) | Crystalline pharmaceutical | |
WO2007062335A2 (en) | New pleuromutilin derivative and its use | |
KR20120060947A (ko) | 신규 고체 물질 {[(2s,5r,8s,11s)-5-벤질-11-(3-구아니디노-프로필)-8-이소프로필-7-메틸-3,6,9,12,15-펜타옥소-1,4,7,10,13-펜타아자-시클로펜타데크-2-일]-아세트산} 및 이의 제조 방법 | |
US20050143445A1 (en) | Novel crystalline forms of levetiracetam | |
US11999750B2 (en) | Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide | |
ZA200206962B (en) | Crystalline pharmaceutical. | |
KR20240035406A (ko) | 트로피네타이드의 결정형 | |
KR20240132504A (ko) | (s)-5-벤질-n-(5-메틸-4-옥소-2,3,4,5-테트라하이드로피리도 [3,2-b][1,4]옥사제핀-3-일)-4h-1,2,4-트리아졸-3-카복사미드의 결정질 형태 | |
CN118632851A (zh) | (S)-5-苄基-N-(5-甲基-4-氧代-2,3,4,5-四氢吡啶并[3,2-b][1,4]氧氮杂卓-3-基)-4H-1,2,4-三唑-3-甲酰胺的晶型 | |
TW202313617A (zh) | PI3Kδ抑制劑的鹽、其晶型、製備方法及用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080319 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110531 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20111220 |